Literature DB >> 27506579

Variation in primary site resection practices for advanced colon cancer: a study using the National Cancer Data Base.

Mark A Healy1, Jason C Pradarelli2, Robert W Krell3, Scott E Regenbogen3, Pasithorn A Suwanabol3.   

Abstract

BACKGROUND: Treatment of metastatic colon cancer may be driven as much by practice patterns as by features of disease. To optimize management, there is a need to better understand what is determining primary site resection use.
METHODS: We evaluated all patients with stage IV cancers in the National Cancer Data Base from 2002 to 2012 (50,791 patients, 1,230 hospitals). We first identified patient characteristics associated with primary tumor resection. Then, we assessed nationwide variation in hospital resection rates.
RESULTS: Overall, 27,387 (53.9%) patients underwent primary site resection. Factors associated with resection included younger age, having less than 2 major comorbidities, and white race (P < .001). Nationwide, hospital-adjusted primary tumor resection rates ranged from 26.0% to 87.8% with broad differences across geographical areas and hospital accreditation types.
CONCLUSIONS: There is statistically significant variation in hospital rates of primary site resection. This demonstrates inconsistent adherence to guidelines in the presence of conflicting evidence regarding resection benefit.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Clinical decision making; Colon neoplasms; Colon surgery; Hospitals; Neoplasm metastasis

Mesh:

Year:  2016        PMID: 27506579      PMCID: PMC5055429          DOI: 10.1016/j.amjsurg.2016.06.003

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  17 in total

1.  Reliability adjustment for reporting hospital outcomes with surgery.

Authors:  Justin B Dimick; Amir A Ghaferi; Nicholas H Osborne; Clifford Y Ko; Bruce L Hall
Journal:  Ann Surg       Date:  2012-04       Impact factor: 12.969

2.  Variation in hospital treatment patterns for metastatic colorectal cancer.

Authors:  Robert W Krell; Scott E Regenbogen; Sandra L Wong
Journal:  Cancer       Date:  2015-01-29       Impact factor: 6.860

3.  Colorectal cancer statistics, 2014.

Authors:  Rebecca Siegel; Carol Desantis; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2014-03-17       Impact factor: 508.702

4.  Time trend analysis of primary tumor resection for stage IV colorectal cancer: less surgery, improved survival.

Authors:  Chung-Yuan Hu; Christina E Bailey; Y Nancy You; John M Skibber; Miguel A Rodriguez-Bigas; Barry W Feig; George J Chang
Journal:  JAMA Surg       Date:  2015-03-01       Impact factor: 14.766

Review 5.  Non-resection versus resection for an asymptomatic primary tumour in patients with unresectable stage IV colorectal cancer.

Authors:  Roberto Cirocchi; Stefano Trastulli; Iosief Abraha; Nereo Vettoretto; Carlo Boselli; Alessandro Montedori; Amilcare Parisi; Giuseppe Noya; Cameron Platell
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

6.  Meta-analysis of survival of patients with stage IV colorectal cancer managed with surgical resection versus chemotherapy alone.

Authors:  A P Stillwell; P G Buettner; Y H Ho
Journal:  World J Surg       Date:  2010-04       Impact factor: 3.352

7.  The national cancer data base: past, present, and future.

Authors:  David P Winchester; Andrew K Stewart; Jerri Linn Phillips; Elizabeth E Ward
Journal:  Ann Surg Oncol       Date:  2009-10-22       Impact factor: 5.344

8.  The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience.

Authors:  S Yousuf Zafar; Jeffrey M Peppercorn; Deborah Schrag; Donald H Taylor; Amy M Goetzinger; Xiaoyin Zhong; Amy P Abernethy
Journal:  Oncologist       Date:  2013-02-26

9.  The personal financial burden of complications after colorectal cancer surgery.

Authors:  Scott E Regenbogen; Christine M Veenstra; Sarah T Hawley; Mousumi Banerjee; Kevin C Ward; Ikuko Kato; Arden M Morris
Journal:  Cancer       Date:  2014-05-29       Impact factor: 6.860

10.  The National Cancer Data Base: a powerful initiative to improve cancer care in the United States.

Authors:  Karl Y Bilimoria; Andrew K Stewart; David P Winchester; Clifford Y Ko
Journal:  Ann Surg Oncol       Date:  2008-01-09       Impact factor: 5.344

View more
  1 in total

1.  De novo metastasis in breast cancer: occurrence and overall survival stratified by molecular subtype.

Authors:  David J Press; Megan E Miller; Erik Liederbach; Katherine Yao; Dezheng Huo
Journal:  Clin Exp Metastasis       Date:  2017-12-29       Impact factor: 5.150

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.